During the past decade, University Oncology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Oncology Associates" #1 collaborator was "Aventis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University Oncology Associates" are "Non-Small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Squamous Non-Small Cell Lung" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "University Oncology Associates" in a lesser frequency.

Most popular intervention types in "University Oncology Associates" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Gemcitabine" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Oncology Associates" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University Oncology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Oncology Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".